These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

814 related items for PubMed ID: 11650078

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. FDA's new rule on treatment use and sale of investigational new drugs.
    Levine RJ.
    IRB; 1987; 9(4):1-4. PubMed ID: 11649946
    [No Abstract] [Full Text] [Related]

  • 3. IRB review of a Phase II randomized clinical trial involving incompetent patients suffering from severe closed head injury.
    Prentice ED, Antonson DL, Leibrock LG, Kelso TK, Sears TD.
    IRB; 1993; 15(5):1-7. PubMed ID: 11659703
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. An IRB member's perspective on access to innovative therapy.
    Moore DL.
    Albany Law Rev; 1994; 57(3):559-81. PubMed ID: 11652854
    [No Abstract] [Full Text] [Related]

  • 6. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
    Kobasic DM.
    J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Multicenter trials and subject eligibility: should local IRBs play a role?
    Freedman B.
    IRB; 1994; 16(1-2):1-6. PubMed ID: 11652320
    [No Abstract] [Full Text] [Related]

  • 11. Considering experimentation and elusive truth: informed consent made difficult.
    Brodeur D.
    Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444
    [No Abstract] [Full Text] [Related]

  • 12. Reviewing subject recruitment: new rules from Rockville.
    McMahon FG.
    IRB; 1988; 10(3):6-7. PubMed ID: 11651911
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. IRB review of adverse events in investigational drug studies.
    Prentice ED, Gordon B.
    IRB; 1997; 19(6):1-4. PubMed ID: 11656910
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. FDA revises informed consent regulations for emergency research.
    Menasché A, Levine RJ.
    IRB; 1995; 17(5-6):19-22. PubMed ID: 11653359
    [No Abstract] [Full Text] [Related]

  • 18. Regulatory orphans: juvenile prisoners as transvulnerable research subjects.
    Reed JG.
    IRB; 1999; 21(2):9-14. PubMed ID: 11657875
    [No Abstract] [Full Text] [Related]

  • 19. Is this a job for the IRB? The case of the ELISA assay.
    Holder AR.
    IRB; 1985; 7(6):7-8. PubMed ID: 11649689
    [No Abstract] [Full Text] [Related]

  • 20. Testing drugs in pediatric populations: the FDA mandate.
    Tauer CA.
    Account Res; 1999; 7(1):37-58. PubMed ID: 11657562
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.